Wall Street brokerages forecast that Galena Biopharma, Inc. (NYSE:SLS) will announce earnings per share (EPS) of ($0.18) for the current quarter, Zacks reports. Zero analysts have made estimates for Galena Biopharma’s earnings. Galena Biopharma reported earnings of ($1.26) per share during the same quarter last year, which would indicate a positive year over year growth rate of 85.7%. The firm is expected to announce its next earnings results on Wednesday, August 21st.
According to Zacks, analysts expect that Galena Biopharma will report full-year earnings of ($0.83) per share for the current year. For the next fiscal year, analysts anticipate that the company will post earnings of ($0.97) per share. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Galena Biopharma.
Galena Biopharma (NYSE:SLS) last posted its quarterly earnings results on Friday, March 22nd. The company reported ($0.47) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.31) by ($0.16).
SLS opened at $0.58 on Friday. Galena Biopharma has a fifty-two week low of $0.58 and a fifty-two week high of $6.97.
Galena Biopharma Company Profile
Recommended Story: Why does a company issue an IPO?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Galena Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galena Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.